COVID-19 Impact on Global Acute Ischemic Stroke Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: C04E7A2720E8EN
QYResearch

Abstracts

This report focuses on the global Acute Ischemic Stroke Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Ischemic Stroke Drugs development in North America, Europe, China and Japan.
The key players covered in this study

• Sanofi
• Biogen
• Bayer
• Pfizer
• Roche
• Boehringer Ingelheim
• Daiichi Sankyo
• Bristol-Myers Squibb
• Johnson?Johnson
• AstraZeneca
• ZZ Biotech
• NoNO Inc
• Athersys
• SanBio

Market segment by Type, the product can be split into

• Tablet
• Capsule
• Other

Market segment by Application, split into

• Hospitals
• Diagnostic Centers
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan

The study objectives of this report are:

• To analyze global Acute Ischemic Stroke Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Acute Ischemic Stroke Drugs development in North America, Europe, China and Japan.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Acute Ischemic Stroke Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Ischemic Stroke Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Tablet
  1.4.3 Capsule
  1.4.4 Other
1.5 Market by Application
  1.5.1 Global Acute Ischemic Stroke Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Diagnostic Centers
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Acute Ischemic Stroke Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Acute Ischemic Stroke Drugs Industry
    1.6.1.1 Acute Ischemic Stroke Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Acute Ischemic Stroke Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Acute Ischemic Stroke Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Acute Ischemic Stroke Drugs Market Perspective (2015-2026)
2.2 Acute Ischemic Stroke Drugs Growth Trends by Regions
  2.2.1 Acute Ischemic Stroke Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Acute Ischemic Stroke Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Acute Ischemic Stroke Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Acute Ischemic Stroke Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Acute Ischemic Stroke Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Acute Ischemic Stroke Drugs Players by Market Size
  3.1.1 Global Top Acute Ischemic Stroke Drugs Players by Revenue (2015-2020)
  3.1.2 Global Acute Ischemic Stroke Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Acute Ischemic Stroke Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Ischemic Stroke Drugs Market Concentration Ratio
  3.2.1 Global Acute Ischemic Stroke Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Acute Ischemic Stroke Drugs Revenue in 2019
3.3 Acute Ischemic Stroke Drugs Key Players Head office and Area Served
3.4 Key Players Acute Ischemic Stroke Drugs Product Solution and Service
3.5 Date of Enter into Acute Ischemic Stroke Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Acute Ischemic Stroke Drugs Historic Market Size by Type (2015-2020)
4.2 Global Acute Ischemic Stroke Drugs Forecasted Market Size by Type (2021-2026)

5 ACUTE ISCHEMIC STROKE DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Acute Ischemic Stroke Drugs Market Size by Application (2015-2020)
5.2 Global Acute Ischemic Stroke Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Acute Ischemic Stroke Drugs Market Size (2015-2020)
6.2 Acute Ischemic Stroke Drugs Key Players in North America (2019-2020)
6.3 North America Acute Ischemic Stroke Drugs Market Size by Type (2015-2020)
6.4 North America Acute Ischemic Stroke Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Acute Ischemic Stroke Drugs Market Size (2015-2020)
7.2 Acute Ischemic Stroke Drugs Key Players in Europe (2019-2020)
7.3 Europe Acute Ischemic Stroke Drugs Market Size by Type (2015-2020)
7.4 Europe Acute Ischemic Stroke Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Acute Ischemic Stroke Drugs Market Size (2015-2020)
8.2 Acute Ischemic Stroke Drugs Key Players in China (2019-2020)
8.3 China Acute Ischemic Stroke Drugs Market Size by Type (2015-2020)
8.4 China Acute Ischemic Stroke Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Acute Ischemic Stroke Drugs Market Size (2015-2020)
9.2 Acute Ischemic Stroke Drugs Key Players in Japan (2019-2020)
9.3 Japan Acute Ischemic Stroke Drugs Market Size by Type (2015-2020)
9.4 Japan Acute Ischemic Stroke Drugs Market Size by Application (2015-2020)

10 KEY PLAYERS PROFILES

10.1 Sanofi
  10.1.1 Sanofi Company Details
  10.1.2 Sanofi Business Overview and Its Total Revenue
  10.1.3 Sanofi Acute Ischemic Stroke Drugs Introduction
  10.1.4 Sanofi Revenue in Acute Ischemic Stroke Drugs Business (2015-2020))
  10.1.5 Sanofi Recent Development
10.2 Biogen
  10.2.1 Biogen Company Details
  10.2.2 Biogen Business Overview and Its Total Revenue
  10.2.3 Biogen Acute Ischemic Stroke Drugs Introduction
  10.2.4 Biogen Revenue in Acute Ischemic Stroke Drugs Business (2015-2020)
  10.2.5 Biogen Recent Development
10.3 Bayer
  10.3.1 Bayer Company Details
  10.3.2 Bayer Business Overview and Its Total Revenue
  10.3.3 Bayer Acute Ischemic Stroke Drugs Introduction
  10.3.4 Bayer Revenue in Acute Ischemic Stroke Drugs Business (2015-2020)
  10.3.5 Bayer Recent Development
10.4 Pfizer
  10.4.1 Pfizer Company Details
  10.4.2 Pfizer Business Overview and Its Total Revenue
  10.4.3 Pfizer Acute Ischemic Stroke Drugs Introduction
  10.4.4 Pfizer Revenue in Acute Ischemic Stroke Drugs Business (2015-2020)
  10.4.5 Pfizer Recent Development
10.5 Roche
  10.5.1 Roche Company Details
  10.5.2 Roche Business Overview and Its Total Revenue
  10.5.3 Roche Acute Ischemic Stroke Drugs Introduction
  10.5.4 Roche Revenue in Acute Ischemic Stroke Drugs Business (2015-2020)
  10.5.5 Roche Recent Development
10.6 Boehringer Ingelheim
  10.6.1 Boehringer Ingelheim Company Details
  10.6.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  10.6.3 Boehringer Ingelheim Acute Ischemic Stroke Drugs Introduction
  10.6.4 Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business (2015-2020)
  10.6.5 Boehringer Ingelheim Recent Development
10.7 Daiichi Sankyo
  10.7.1 Daiichi Sankyo Company Details
  10.7.2 Daiichi Sankyo Business Overview and Its Total Revenue
  10.7.3 Daiichi Sankyo Acute Ischemic Stroke Drugs Introduction
  10.7.4 Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business (2015-2020)
  10.7.5 Daiichi Sankyo Recent Development
10.8 Bristol-Myers Squibb
  10.8.1 Bristol-Myers Squibb Company Details
  10.8.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  10.8.3 Bristol-Myers Squibb Acute Ischemic Stroke Drugs Introduction
  10.8.4 Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business (2015-2020)
  10.8.5 Bristol-Myers Squibb Recent Development
10.9 Johnson?Johnson
  10.9.1 Johnson?Johnson Company Details
  10.9.2 Johnson?Johnson Business Overview and Its Total Revenue
  10.9.3 Johnson?Johnson Acute Ischemic Stroke Drugs Introduction
  10.9.4 Johnson?Johnson Revenue in Acute Ischemic Stroke Drugs Business (2015-2020)
  10.9.5 Johnson?Johnson Recent Development
10.10 AstraZeneca
  10.10.1 AstraZeneca Company Details
  10.10.2 AstraZeneca Business Overview and Its Total Revenue
  10.10.3 AstraZeneca Acute Ischemic Stroke Drugs Introduction
  10.10.4 AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business (2015-2020)
  10.10.5 AstraZeneca Recent Development
10.11 ZZ Biotech
  10.11.1 ZZ Biotech Company Details
  10.11.2 ZZ Biotech Business Overview and Its Total Revenue
  10.11.3 ZZ Biotech Acute Ischemic Stroke Drugs Introduction
  10.11.4 ZZ Biotech Revenue in Acute Ischemic Stroke Drugs Business (2015-2020)
  10.11.5 ZZ Biotech Recent Development
10.12 NoNO Inc
  10.12.1 NoNO Inc Company Details
  10.12.2 NoNO Inc Business Overview and Its Total Revenue
  10.12.3 NoNO Inc Acute Ischemic Stroke Drugs Introduction
  10.12.4 NoNO Inc Revenue in Acute Ischemic Stroke Drugs Business (2015-2020)
  10.12.5 NoNO Inc Recent Development
10.13 Athersys
  10.13.1 Athersys Company Details
  10.13.2 Athersys Business Overview and Its Total Revenue
  10.13.3 Athersys Acute Ischemic Stroke Drugs Introduction
  10.13.4 Athersys Revenue in Acute Ischemic Stroke Drugs Business (2015-2020)
  10.13.5 Athersys Recent Development
10.14 SanBio
  10.14.1 SanBio Company Details
  10.14.2 SanBio Business Overview and Its Total Revenue
  10.14.3 SanBio Acute Ischemic Stroke Drugs Introduction
  10.14.4 SanBio Revenue in Acute Ischemic Stroke Drugs Business (2015-2020)
  10.14.5 SanBio Recent Development

11 ANALYST'S VIEWPOINTS/CONCLUSIONS

12 APPENDIX

12.1 Research Methodology
  12.1.1 Methodology/Research Approach
  12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Acute Ischemic Stroke Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Ischemic Stroke Drugs Revenue
Table 3. Ranking of Global Top Acute Ischemic Stroke Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tablet
Table 6. Key Players of Capsule
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Acute Ischemic Stroke Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Acute Ischemic Stroke Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Acute Ischemic Stroke Drugs Players to Combat Covid-19 Impact
Table 13. Global Acute Ischemic Stroke Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Acute Ischemic Stroke Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Acute Ischemic Stroke Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Acute Ischemic Stroke Drugs Market Share by Regions (2015-2020)
Table 17. Global Acute Ischemic Stroke Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Acute Ischemic Stroke Drugs Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Acute Ischemic Stroke Drugs Market Growth Strategy
Table 23. Main Points Interviewed from Key Acute Ischemic Stroke Drugs Players
Table 24. Global Acute Ischemic Stroke Drugs Revenue by Players (2015-2020) (Million US$)
Table 25. Global Acute Ischemic Stroke Drugs Market Share by Players (2015-2020)
Table 26. Global Top Acute Ischemic Stroke Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Ischemic Stroke Drugs as of 2019)
Table 27. Global Acute Ischemic Stroke Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Acute Ischemic Stroke Drugs Product Solution and Service
Table 30. Date of Enter into Acute Ischemic Stroke Drugs Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Acute Ischemic Stroke Drugs Market Size by Type (2015-2020) (Million US$)
Table 33. Global Acute Ischemic Stroke Drugs Market Size Share by Type (2015-2020)
Table 34. Global Acute Ischemic Stroke Drugs Revenue Market Share by Type (2021-2026)
Table 35. Global Acute Ischemic Stroke Drugs Market Size Share by Application (2015-2020)
Table 36. Global Acute Ischemic Stroke Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. Global Acute Ischemic Stroke Drugs Market Size Share by Application (2021-2026)
Table 38. North America Key Players Acute Ischemic Stroke Drugs Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Acute Ischemic Stroke Drugs Market Share (2019-2020)
Table 40. North America Acute Ischemic Stroke Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. North America Acute Ischemic Stroke Drugs Market Share by Type (2015-2020)
Table 42. North America Acute Ischemic Stroke Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. North America Acute Ischemic Stroke Drugs Market Share by Application (2015-2020)
Table 44. Europe Key Players Acute Ischemic Stroke Drugs Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Acute Ischemic Stroke Drugs Market Share (2019-2020)
Table 46. Europe Acute Ischemic Stroke Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Acute Ischemic Stroke Drugs Market Share by Type (2015-2020)
Table 48. Europe Acute Ischemic Stroke Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Acute Ischemic Stroke Drugs Market Share by Application (2015-2020)
Table 50. China Key Players Acute Ischemic Stroke Drugs Revenue (2019-2020) (Million US$)
Table 51. China Key Players Acute Ischemic Stroke Drugs Market Share (2019-2020)
Table 52. China Acute Ischemic Stroke Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. China Acute Ischemic Stroke Drugs Market Share by Type (2015-2020)
Table 54. China Acute Ischemic Stroke Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. China Acute Ischemic Stroke Drugs Market Share by Application (2015-2020)
Table 56. Japan Key Players Acute Ischemic Stroke Drugs Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Acute Ischemic Stroke Drugs Market Share (2019-2020)
Table 58. Japan Acute Ischemic Stroke Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Acute Ischemic Stroke Drugs Market Share by Type (2015-2020)
Table 60. Japan Acute Ischemic Stroke Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Acute Ischemic Stroke Drugs Market Share by Application (2015-2020)
Table 62. Sanofi Company Details
Table 63. Sanofi Business Overview
Table 64. Sanofi Product
Table 65. Sanofi Revenue in Acute Ischemic Stroke Drugs Business (2015-2020) (Million US$)
Table 66. Sanofi Recent Development
Table 67. Biogen Company Details
Table 68. Biogen Business Overview
Table 69. Biogen Product
Table 70. Biogen Revenue in Acute Ischemic Stroke Drugs Business (2015-2020) (Million US$)
Table 71. Biogen Recent Development
Table 72. Bayer Company Details
Table 73. Bayer Business Overview
Table 74. Bayer Product
Table 75. Bayer Revenue in Acute Ischemic Stroke Drugs Business (2015-2020) (Million US$)
Table 76. Bayer Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Product
Table 80. Pfizer Revenue in Acute Ischemic Stroke Drugs Business (2015-2020) (Million US$)
Table 81. Pfizer Recent Development
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Product
Table 85. Roche Revenue in Acute Ischemic Stroke Drugs Business (2015-2020) (Million US$)
Table 86. Roche Recent Development
Table 87. Boehringer Ingelheim Company Details
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Product
Table 90. Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business (2015-2020) (Million US$)
Table 91. Boehringer Ingelheim Recent Development
Table 92. Daiichi Sankyo Company Details
Table 93. Daiichi Sankyo Business Overview
Table 94. Daiichi Sankyo Product
Table 95. Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business (2015-2020) (Million US$)
Table 96. Daiichi Sankyo Recent Development
Table 97. Bristol-Myers Squibb Business Overview
Table 98. Bristol-Myers Squibb Product
Table 99. Bristol-Myers Squibb Company Details
Table 100. Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business (2015-2020) (Million US$)
Table 101. Bristol-Myers Squibb Recent Development
Table 102. Johnson?Johnson Company Details
Table 103. Johnson?Johnson Business Overview
Table 104. Johnson?Johnson Product
Table 105. Johnson?Johnson Revenue in Acute Ischemic Stroke Drugs Business (2015-2020) (Million US$)
Table 106. Johnson?Johnson Recent Development
Table 107. AstraZeneca Company Details
Table 108. AstraZeneca Business Overview
Table 109. AstraZeneca Product
Table 110. AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business (2015-2020) (Million US$)
Table 111. AstraZeneca Recent Development
Table 112. ZZ Biotech Company Details
Table 113. ZZ Biotech Business Overview
Table 114. ZZ Biotech Product
Table 115. ZZ Biotech Revenue in Acute Ischemic Stroke Drugs Business (2015-2020) (Million US$)
Table 116. ZZ Biotech Recent Development
Table 117. NoNO Inc Company Details
Table 118. NoNO Inc Business Overview
Table 119. NoNO Inc Product
Table 120. NoNO Inc Revenue in Acute Ischemic Stroke Drugs Business (2015-2020) (Million US$)
Table 121. NoNO Inc Recent Development
Table 122. Athersys Company Details
Table 123. Athersys Business Overview
Table 124. Athersys Product
Table 125. Athersys Revenue in Acute Ischemic Stroke Drugs Business (2015-2020) (Million US$)
Table 126. Athersys Recent Development
Table 127. SanBio Company Details
Table 128. SanBio Business Overview
Table 129. SanBio Product
Table 130. SanBio Revenue in Acute Ischemic Stroke Drugs Business (2015-2020) (Million US$)
Table 131. SanBio Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Acute Ischemic Stroke Drugs Market Share by Type: 2020 VS 2026
Figure 2. Tablet Features
Figure 3. Capsule Features
Figure 4. Other Features
Figure 5. Global Acute Ischemic Stroke Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Acute Ischemic Stroke Drugs Report Years Considered
Figure 10. Global Acute Ischemic Stroke Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Acute Ischemic Stroke Drugs Market Share by Regions: 2020 VS 2026
Figure 12. Global Acute Ischemic Stroke Drugs Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Acute Ischemic Stroke Drugs Market Share by Players in 2019
Figure 15. Global Top Acute Ischemic Stroke Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Ischemic Stroke Drugs as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Acute Ischemic Stroke Drugs Revenue in 2019
Figure 17. North America Acute Ischemic Stroke Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Acute Ischemic Stroke Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Acute Ischemic Stroke Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Acute Ischemic Stroke Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Sanofi Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2015-2020)
Figure 23. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Biogen Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2015-2020)
Figure 25. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bayer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2015-2020)
Figure 27. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Pfizer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2015-2020)
Figure 29. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Roche Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2015-2020)
Figure 31. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Boehringer Ingelheim Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2015-2020)
Figure 33. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Daiichi Sankyo Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2015-2020)
Figure 35. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Bristol-Myers Squibb Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2015-2020)
Figure 37. Johnson?Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Johnson?Johnson Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2015-2020)
Figure 39. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. AstraZeneca Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2015-2020)
Figure 41. ZZ Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. ZZ Biotech Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2015-2020)
Figure 43. NoNO Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. NoNO Inc Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2015-2020)
Figure 45. Athersys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Athersys Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2015-2020)
Figure 47. SanBio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. SanBio Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed